![Mattias Karlsson](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Mattias Karlsson
Corporate Officer/Principal bei Cellectricon AB
Profil
Mattias Karlsson is currently working as the Vice President-Business Development at Cellectricon AB since 2003.
He holds a doctorate degree from Chalmers University of Technology and a graduate degree from the University of Gothenburg.
Aktive Positionen von Mattias Karlsson
Unternehmen | Position | Beginn |
---|---|---|
Cellectricon AB
![]() Cellectricon AB Miscellaneous Commercial ServicesCommercial Services Cellectricon AB provides cell-based screening services to accelerate drug discovery. The firm develops and validates exciting central nervous system and peripheral pain assays using primary cells, accelerating the path from assay validation to compound screening. Its system is equipped with an imaging-based microplate reader to simultaneously record transient fluorescence and luminescence signals, providing real-time monitoring and readouts of cell culture response. The company was founded by Jan Owe Owesson Orwar, Daniel T. Chiu and Stig Anders Jakob Lindberg in 1999 and is headquartered in Molndal, Sweden. | Corporate Officer/Principal | 01.01.2003 |
Ausbildung von Mattias Karlsson
Chalmers University of Technology | Doctorate Degree |
University of Gothenburg | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Cellectricon AB
![]() Cellectricon AB Miscellaneous Commercial ServicesCommercial Services Cellectricon AB provides cell-based screening services to accelerate drug discovery. The firm develops and validates exciting central nervous system and peripheral pain assays using primary cells, accelerating the path from assay validation to compound screening. Its system is equipped with an imaging-based microplate reader to simultaneously record transient fluorescence and luminescence signals, providing real-time monitoring and readouts of cell culture response. The company was founded by Jan Owe Owesson Orwar, Daniel T. Chiu and Stig Anders Jakob Lindberg in 1999 and is headquartered in Molndal, Sweden. | Commercial Services |